![Felix Frueh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Felix Frueh
Direktor/Vorstandsmitglied bei GENINCODE PLC
Vermögen: 9 867 $ am 31.05.2024
Aktive Positionen von Felix Frueh
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GENINCODE PLC | Direktor/Vorstandsmitglied | 06.04.2022 | - |
Independent Dir/Board Member | 06.04.2022 | - | |
Profound Ventures LLC
![]() Profound Ventures LLC Investment ManagersFinance Profound Ventures LLC solves profound societal problems. It engaged in creating, seed funding, and growing new business ventures and non-profit organizations to solve. The company was founded by Felix Frueh and Brian Meshkin and is headquartered in Newport Beach, CA. | Gründer | - | - |
Corporate Officer/Principal | - | - |
Karriereverlauf von Felix Frueh
Ehemalige bekannte Positionen von Felix Frueh
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Georgetown University | Corporate Officer/Principal | 31.12.2000 | 31.12.2000 |
Protogene Laboratories, Inc. | Corporate Officer/Principal | 31.12.2000 | 31.12.2000 |
King Pharmaceuticals Research & Development, Inc. | Präsident | - | - |
Opus Three LLC | Corporate Officer/Principal | - | - |
Human Longevity, Inc.
![]() Human Longevity, Inc. BiotechnologyHealth Technology Human Longevity, Inc. provides precision health analytics to individuals through the Health Nucleus. The Health Nucleus is an assessment of current and future risk for cardiac, oncologic, metabolic and cognitive diseases and conditions. The firm offers database of sequenced genomes and phenotypic data. The company was founded by J. Craig Venter, Robert Joseph Hariri Gordon, and Peter H. Diamandis in 2013 and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Intellos Health LLC | Vorstandsvorsitzender | - | - |
Selva Therapeutics, Inc.
![]() Selva Therapeutics, Inc. BiotechnologyHealth Technology Selva Therapeutics, Inc. is a privately held biotechnology company based in San Mateo, CA. Selva Therapeutics is focused on rapidly developing slv213 for COVID-19 and aims to bring a valuable treatment to the market that has the potential to fight multiple life-threatening infectious diseases. Selva Therapeutics, Inc. was founded by Felix Wilhelm Frueh and Thomas E. Daley. The CEO is Thomas E. Daley. | Direktor/Vorstandsmitglied | - | - |
Technik-/Wissenschafts-/F&E-Leiter | - | - | |
Gründer | - | - | |
░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | - | - | |
░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░ ░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Felix Frueh
University of Basel | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 11 |
Frankreich | 3 |
Schweiz | 2 |
Operativ
Corporate Officer/Principal | 5 |
Director/Board Member | 4 |
Independent Dir/Board Member | 2 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Finance | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GENINCODE PLC | Technology Services |
Private Unternehmen | 11 |
---|---|
King Pharmaceuticals Research & Development, Inc. | Health Technology |
Transgenomic, Inc.
![]() Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Health Technology |
Ariana Pharmaceuticals SA
![]() Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France. | Health Technology |
Protogene Laboratories, Inc. | |
Enterome SA
![]() Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Health Technology |
Human Longevity, Inc.
![]() Human Longevity, Inc. BiotechnologyHealth Technology Human Longevity, Inc. provides precision health analytics to individuals through the Health Nucleus. The Health Nucleus is an assessment of current and future risk for cardiac, oncologic, metabolic and cognitive diseases and conditions. The firm offers database of sequenced genomes and phenotypic data. The company was founded by J. Craig Venter, Robert Joseph Hariri Gordon, and Peter H. Diamandis in 2013 and is headquartered in San Diego, CA. | Health Technology |
Profound Ventures LLC
![]() Profound Ventures LLC Investment ManagersFinance Profound Ventures LLC solves profound societal problems. It engaged in creating, seed funding, and growing new business ventures and non-profit organizations to solve. The company was founded by Felix Frueh and Brian Meshkin and is headquartered in Newport Beach, CA. | Finance |
Selva Therapeutics, Inc.
![]() Selva Therapeutics, Inc. BiotechnologyHealth Technology Selva Therapeutics, Inc. is a privately held biotechnology company based in San Mateo, CA. Selva Therapeutics is focused on rapidly developing slv213 for COVID-19 and aims to bring a valuable treatment to the market that has the potential to fight multiple life-threatening infectious diseases. Selva Therapeutics, Inc. was founded by Felix Wilhelm Frueh and Thomas E. Daley. The CEO is Thomas E. Daley. | Health Technology |
Intellos Health LLC | |
Opus Three LLC | |
Third Rock Ventures LLC
![]() Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Finance |
- Börse
- Insiders
- Felix Frueh
- Erfahrung